In the last fifteen years, therapeutic use of intravenous immunoglobulin on one hand, and of bone marrow transplantation on the other, have largely modified survival rate and prognosis for many primary immunodeficiency diseases. At the same time, major advances in molecular genetics have allowed mapping of several immunodeficiency genes and made prenatal diagnosis feasible. Furthermore, for many X-linked immunodeficiencies, carrier detection can be also accomplished by means of analysis of the pattern of X-chromosome inactivation. As a whole, these techniques have substantially contributed to a more accurate genetic counseling in the families
Gene therapy with hematopoietic stem cells (HSC) is an attractive therapeutic strategy for several f...
Primary immunodeficiencies (PIDs)* belong to the group of rare diseases which need more awareness by...
Primary immunodeficiency disorders (PIDs) are rare inherited monogenic disorders of the immune syste...
In the last fifteen years, therapeutic use of intravenous immunoglobulin on one hand, and of bone ma...
The occurrence of primary immunodeficiency diseases (PIDs) is low compared to that of immune-mediate...
The most severe primary immune deficiency diseases (PIDs) have been successfully treated with alloge...
The use of gene therapy in the treatment of primary immune deficiencies (PID) has advanced significa...
In the recent past, the gene therapy field has witnessed a remarkable series of successes, many of w...
Gene therapy is an innovative treatment for Primary Immune Deficiencies (PIDs) that uses autologous ...
Prior to the first successful bone marrow transplant in 1968, patients born with severe combined imm...
The technological advances in diagnostics and therapy of primary immunodeficiency are progressing at...
Primary immunodeficiency disorders in childhood usually present as unusual, recurrent or severe infe...
Over 120 inherited primary immunodeficiency diseases (PIDs) are known to exist. The genes responsibl...
The year 2000 saw the first successful treatment of a genetic disorder by gene therapy. Pediatric pa...
Genetic testing has become important in the repertoire for the diagnosis of primary immunodeficienci...
Gene therapy with hematopoietic stem cells (HSC) is an attractive therapeutic strategy for several f...
Primary immunodeficiencies (PIDs)* belong to the group of rare diseases which need more awareness by...
Primary immunodeficiency disorders (PIDs) are rare inherited monogenic disorders of the immune syste...
In the last fifteen years, therapeutic use of intravenous immunoglobulin on one hand, and of bone ma...
The occurrence of primary immunodeficiency diseases (PIDs) is low compared to that of immune-mediate...
The most severe primary immune deficiency diseases (PIDs) have been successfully treated with alloge...
The use of gene therapy in the treatment of primary immune deficiencies (PID) has advanced significa...
In the recent past, the gene therapy field has witnessed a remarkable series of successes, many of w...
Gene therapy is an innovative treatment for Primary Immune Deficiencies (PIDs) that uses autologous ...
Prior to the first successful bone marrow transplant in 1968, patients born with severe combined imm...
The technological advances in diagnostics and therapy of primary immunodeficiency are progressing at...
Primary immunodeficiency disorders in childhood usually present as unusual, recurrent or severe infe...
Over 120 inherited primary immunodeficiency diseases (PIDs) are known to exist. The genes responsibl...
The year 2000 saw the first successful treatment of a genetic disorder by gene therapy. Pediatric pa...
Genetic testing has become important in the repertoire for the diagnosis of primary immunodeficienci...
Gene therapy with hematopoietic stem cells (HSC) is an attractive therapeutic strategy for several f...
Primary immunodeficiencies (PIDs)* belong to the group of rare diseases which need more awareness by...
Primary immunodeficiency disorders (PIDs) are rare inherited monogenic disorders of the immune syste...